Operating
Other Noncash Income (Expense)
Edwards Lifesciences Other Noncash Income (Expense) increased by 90.7% to -$500.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 86.1%, from -$3.60M to -$500.00K. Over 4 years (FY 2021 to FY 2025), Other Noncash Income (Expense) shows a downward trend with a -24.3% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 6, 2026
How to read this metric
Large fluctuations may indicate one-time accounting adjustments or non-recurring non-cash events that require further investigation.
Detailed definition
This category aggregates various non-cash items that do not fit into standard categories like depreciation or stock-base...
Peer comparison
Standard line item in cash flow statements; peers use this to capture miscellaneous non-cash accounting impacts.
Metric ID:
operating_other_noncash_income_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.50M | $3.10M | $7.10M | -$20.40M | $16.20M | -$1.30M | -$2.30M | -$400.00K | -$2.40M | -$1.60M | -$4.00M | $500.00K | -$2.50M | -$700.00K | -$15.70M | -$3.60M | -$4.70M | $6.00M | -$5.40M | -$500.00K |
| QoQ Change | — | -70.5% | +129.0% | -387.3% | +179.4% | -108.0% | -76.9% | +82.6% | -500.0% | +33.3% | -150.0% | +112.5% | -600.0% | +72.0% | <-999% | +77.1% | -30.6% | +227.7% | -190.0% | +90.7% |
| YoY Change | — | — | — | — | +54.3% | -141.9% | -132.4% | +98.0% | -114.8% | -23.1% | -73.9% | +225.0% | -4.2% | +56.3% | -292.5% | -820.0% | -88.0% | +957.1% | +65.6% | +86.1% |
Range-$20.40M – $16.20M
CAGR-47.3%
Avg YoY Growth-9.3%
Median YoY Growth-13.6%
Other Noncash Income (Expense) at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's other noncash income (expense)?
- Edwards Lifesciences (EW) reported other noncash income (expense) of -$500.00K in Q1 2026.
- How has Edwards Lifesciences's other noncash income (expense) changed year-over-year?
- Edwards Lifesciences's other noncash income (expense) increased by 86.1% year-over-year, from -$3.60M to -$500.00K.
- What is the long-term trend for Edwards Lifesciences's other noncash income (expense)?
- Over 4 years (2021 to 2025), Edwards Lifesciences's other noncash income (expense) has grown at a -24.3% compound annual growth rate (CAGR), from $23.40M to -$7.70M.
- What does other noncash income (expense) mean?
- Miscellaneous non-cash income or expenses that impact net income but not cash flow.